Realtime | Geld | Brief | Zeit |
---|---|---|---|
10,800 | 11,300 | 20:43 | |
11,000 | 11,100 | 20:41 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
13.01. | Paragon 28 announces preliminary Q4 revenue in range of $71.5 to $71.8 million | 1 | Seeking Alpha | ||
13.01. | Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024 | 53 | Business Wire | ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA) ("Paragon 28" or "P28"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced... ► Artikel lesen | |
13.01. | Paragon 28, Inc. - 8-K, Current Report | - | SEC Filings | ||
11.12.24 | Paragon 28 erweitert Vorstand mit neuem Direktor | 1 | Investing.com Deutsch | ||
11.12.24 | Paragon 28 expands board with new director | 1 | Investing.com | ||
PARAGON 28 Aktie jetzt für 0€ handeln | |||||
10.12.24 | Paragon 28 verzeichnet Aktienverkäufe von 401.384 US-Dollar durch MVM Partners | 1 | Investing.com Deutsch | ||
10.12.24 | Paragon 28-Direktorin Kristina Wright verkauft Aktien im Wert von 23.602 US-Dollar | 1 | Investing.com Deutsch | ||
06.12.24 | MVM Partners verkauft Paragon 28-Aktien im Wert von 749.061 US-Dollar | 1 | Investing.com Deutsch | ||
29.11.24 | MVM Partners verkauft Paragon 28-Aktien im Wert von 484.020 US-Dollar | 7 | Investing.com Deutsch | ||
12.11.24 | Paragon 28 Reports Third Quarter 2024 Financial Results and Raises 2024 Net Revenue Guidance | 77 | Business Wire | ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA) ("Paragon 28" or "Company"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today... ► Artikel lesen | |
12.11.24 | Paragon 28, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
24.10.24 | Paragon 28 stock hits 52-week low at $4.82 amid market challenges | 4 | Investing.com | ||
24.10.24 | Paragon 28-Aktie erreicht 52-Wochen-Tief bei 4,82 US-Dollar | 2 | Investing.com Deutsch | ||
17.10.24 | Paragon 28's Shares Rise After Launch of Phantom Fibula Nail System | 3 | Zacks | ||
20.09.24 | Paragon 28 announces executive transition | 2 | Investing.com | ||
20.09.24 | Paragon 28 kündigt Führungswechsel an | 3 | Investing.com Deutsch | ||
20.09.24 | Paragon 28, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
09.09.24 | Will Paragon 28 Stock Gain From the Latest Product Launch of R3FLEX? | 1 | Zacks | ||
04.09.24 | Paragon 28 launches new ankle stabilization system | 1 | Investing.com | ||
20.08.24 | Paragon 28 (FNA) Expands SMART 28 Ecosystem With New Launches | 1 | Zacks |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
UNITEDHEALTH | 507,70 | -0,14 % | DAX: Fällt der nächste Rekord? Außerdem: Aktien von Qiagen und UnitedHealth im Fokus | Der DAX hat am Freitag den dritten Rekordtag in Folge verbucht. Kurz vor dem Amtsantritt von Donald Trump als US-Präsident stieg der Leitindex im frühen Handel erstmals über die Marke von 20.700 Punkten.... ► Artikel lesen | |
TELADOC HEALTH | 9,700 | -0,30 % | Amazon Adds Teladoc Health to Health Benefits Program | ||
THERMO FISHER | 548,60 | -0,56 % | Is Thermo Fisher Stock Worth Holding on to in Your Portfolio? | ||
BICO GROUP | 2,806 | -2,77 % | BD And Biosero Partner To Integrate Robotics With Flow Cytometry | WASHINGTON (dpa-AFX) - BD. (BDX), a global medical technology company, and Biosero, a developer of laboratory automation solutions, Thursday announced that they have entered into a framework... ► Artikel lesen | |
HIMS & HERS HEALTH | 29,580 | -0,27 % | Hims & Hers Health: Rechtsvorstand verkauft Aktien im Wert von über 1,6 Millionen US-Dollar | ||
VITA 34 | 4,080 | -1,45 % | Original-Research: Vita 34 AG (von Montega AG): Vita 34 AG | Original-Research: Vita 34 AG - von Montega AG 27.11.2024 / 10:10 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group AG. Für den Inhalt der Mitteilung... ► Artikel lesen | |
DEXCOM | 84,13 | -0,05 % | Dexcom CEO says 2025 is 'shaping up to be a good year' with Stelo launch, GenAI integration | ||
ALCON | 84,67 | -0,76 % | Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference | Regulatory News:
Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2025 J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 4:30 p.m. PST.
A live webcast of the conference... ► Artikel lesen | |
ALIGN TECHNOLOGY | 222,00 | -1,60 % | The Analyst Verdict: Align Tech In The Eyes Of 3 Experts | ||
INMODE | 16,395 | -1,09 % | InMode Ltd.: InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the ... | YOKNEAM, Israel, Oct. 30, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen | |
MCKESSON | 557,20 | -2,79 % | XML Financial LLC Takes Position in McKesson Co. (NYSE:MCK) | ||
BAXTER | 30,805 | -1,09 % | Bear of the Day: Baxter (BAX) | ||
HENRY SCHEIN | 70,82 | -1,31 % | Exclusive-Activist Ananym plans to launch proxy fight at Henry Schein, sources say | ||
SPINEWAY | 0,101 | -0,50 % | Spineway: 2024 revenue of €12 million - 14% growth compared with 2023 | Press release Ecully, January 22, 2025 - 6.30 p.m. SPINEWAY 2024 revenue of €12 million 14% growth compared with 2023 In thousands of euros20242023Change as a %H1 revenue6,5355,431+20%H2... ► Artikel lesen | |
FRESENIUS | 36,720 | -0,22 % | Leichte Zugewinne bei der Fresenius SE & Co. KGaA-Aktie (36,58 €) | Das Wertpapier von Fresenius SE & Co. KGaA notiert heute fester. Der jüngste Kurs betrug 36,58 Euro. Die Fresenius+Co KgaA-Aktie verzeichnet gegenwärtig einen Wertanstieg von 2,75 Prozent. Sie hat sich... ► Artikel lesen |